search
Back to results

Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique

Primary Purpose

Zygomatic Fractures

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
patient specific guide
conventional technique
Sponsored by
Ahmed Morad
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Zygomatic Fractures

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • • Zygomatic Fracture Type III, IV and V according to rowe and killey classification(13)

    • Age (18-60 years)
    • Recent fracture (less than 2 weeks)

Exclusion Criteria:

  • • Zygomatic Fracture Type I, II and VI according to rowe and killey classification(13)

    • Medical compromised patient
    • Patient on radiotherapy
    • Bone disease

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    (ZMC) Fractures reduction Using Patient Specific Guide (PSG)

    (ZMC) Fractures reduction Using Conventional Technique

    Arm Description

    Outcomes

    Primary Outcome Measures

    accuracy of reduction of the fractured zygoma ( facial asymetry )
    assessed by ct

    Secondary Outcome Measures

    operation time
    in hours

    Full Information

    First Posted
    April 1, 2021
    Last Updated
    April 5, 2021
    Sponsor
    Ahmed Morad
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04836130
    Brief Title
    Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique
    Official Title
    Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    May 2021 (Anticipated)
    Primary Completion Date
    May 2022 (Anticipated)
    Study Completion Date
    June 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Ahmed Morad

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures reduction Using Patient Specific Guide (PSG) Versus Conventional Technique

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Zygomatic Fractures

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    26 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    (ZMC) Fractures reduction Using Patient Specific Guide (PSG)
    Arm Type
    Active Comparator
    Arm Title
    (ZMC) Fractures reduction Using Conventional Technique
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    patient specific guide
    Intervention Description
    patient specific guide reduction
    Intervention Type
    Procedure
    Intervention Name(s)
    conventional technique
    Intervention Description
    conventional anatomical reduction
    Primary Outcome Measure Information:
    Title
    accuracy of reduction of the fractured zygoma ( facial asymetry )
    Description
    assessed by ct
    Time Frame
    up to 6 months
    Secondary Outcome Measure Information:
    Title
    operation time
    Description
    in hours
    Time Frame
    up to 6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: • Zygomatic Fracture Type III, IV and V according to rowe and killey classification(13) Age (18-60 years) Recent fracture (less than 2 weeks) Exclusion Criteria: • Zygomatic Fracture Type I, II and VI according to rowe and killey classification(13) Medical compromised patient Patient on radiotherapy Bone disease

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique

    We'll reach out to this number within 24 hrs